OncoDiag

About:

OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities.

Top Investors: Bpifrance, Les Business Angels des Grandes Écoles, AGORANOV, Paris Business Angels, Angels Santé

Description:

OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.

Total Funding Amount:

4.1M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Miserey, Haute-Normandie, France

Founded Date:

2012-05-01

Contact Email:

hennion(AT)oncodiag.fr

Founders:

Claude Hennion, Jean-Pierre Roperch

Number of Employees:

11-50

Last Funding Date:

2021-03-15

IPO Status:

Private

Industries: